Cytarabine liposomal Pregnancy and Breastfeeding Warnings
Cytarabine liposomal is also known as: DepoCyt
Cytarabine liposomal Pregnancy Warnings
Cytarabine liposomal has been assigned to pregnancy category D by the FDA. Animal studies of cytarabine have revealed evidence of teratogenicity and embryotoxicity. There are no controlled data in human pregnancy. Following the intravenous administration of cytarabine (the active component of cytarabine liposomal), three anecdotal cases of major limb malformations have been reported. However, the manufacturer of cytarabine liposomal has stated that the concern for fetal harm following intrathecal cytarabine liposomal is low because systemic exposure to cytarabine is negligible. Cytarabine liposomal should only be given during pregnancy when there are no alternatives and benefit outweighs risk.
Cytarabine liposomal Breastfeeding Warnings
There are no data on the excretion of cytarabine liposomal into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, the use of cytarabine liposomal is not recommended in nursing women.
- cytarabine liposomal Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.